Viewing Study NCT04488003

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:31 PM
Ignite Modification Date: 2026-05-27 @ 5:10 PM
Study NCT ID: NCT04488003
Status: TERMINATED
Last Update Posted: 2024-06-04
First Post: 2020-07-17
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations
Sponsor: BioMed Valley Discoveries, Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
None BRAF Gene Mutation View
None BRAF Gene Alteration View
None MEK Mutation View
None MEK Alteration View
None MAP2K1 Gene Mutation View
None MAP2K1 Gene Alteration View
None MAP2K2 Gene Mutation View
None MAP2K2 Gene Alteration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None atypical BRAF, non-V600 View